When was Advanced Prenatal Therapeutics founded?

Advanced Prenatal Therapeutics was founded in 2012.

Where is Advanced Prenatal Therapeutics located?

Advanced Prenatal Therapeutics is headquartered in Laguna Hills, United States.

How many employees does Advanced Prenatal Therapeutics have?

As of Aug 31, 2026, the latest employee count at Advanced Prenatal Therapeutics is 2.

Where does Advanced Prenatal Therapeutics rank among its competitors?

Advanced Prenatal Therapeutics ranks 27th amongst 31 active competitors, of which 10 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Kove, which secured $1.97M in Aug, 2026.

Who are the top competitors of Advanced Prenatal Therapeutics?

Advanced Prenatal Therapeutics' top competitors include Materna Medical, CooperSurgical and Novocuff. Among them, Kove secured the most recent funding round in August, 2026.

Advanced Prenatal Therapeutics - 2026 Company Profile, Funding & Competitors

Company Details

Developer of targeted apheresis technology for treating clinical preeclampsia. This medical device technology removes specific harmful biomarkers from maternal blood to prolong pregnancy and improve birth outcomes. The system uses column-based filtration to capture antiangiogenic proteins, aiming to stabilize maternal health conditions associated with pregnancy complications.

Website: www.advancedprenatal.com/
Social
Email ID: *****@advancedprenatal.com
Phone Number: +1 **********

Key Metrics

Founded Year

2012

Location

Laguna Hills, United States

Stage

Funding Raised

Investors

Boma Investments

Ranked

27^th among 31 active competitors

Employee Count

2 as on Aug 31, 2026

Similar Companies

Materna Medical & 35 more

View Advanced Prenatal Therapeutics' full profile

Advanced Prenatal Therapeutics is a funded company. Advanced Prenatal Therapeutics has 1 institutional investor.

View details of Advanced Prenatal Therapeutics's funding rounds and investors

Advanced Prenatal Therapeutics' employee count trend

Advanced Prenatal Therapeutics has 2 employees as of Aug 26. Here is Advanced Prenatal Therapeutics's employee count trend over the years:

Employee count trend for Advanced Prenatal Therapeutics

Uncover Advanced Prenatal Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Advanced Prenatal Therapeutics include Materna Medical, CooperSurgical and Novocuff. Here is the list of Top 10 competitors of Advanced Prenatal Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Materna Medical 2010, Mountain View (United States), Series B	Provider of medical devices for women's pelvic health	$62.7M	InnovaHealth Partners, Wavemaker 360 & 17 others	62/100
2nd	CooperSurgical 1990, Trumbull (United States), Unfunded	Provider of devices and surgical instruments for pregnancy	-	-	44/100
3rd	Novocuff 2021, San Luis Obispo (United States), Series A	Developer of medical device to prevent infant mortality caused by preterm birth complications	$28M	Laerdal Million Lives Fund, AXA Investment Managers ... & 6 others	42/100
4th	Clinical Innovations 1993, Murray (United States), Acquired	Medical technology company focused on restoring dignity through innovative diagnostic solutions	-	Curewell Capital, Meadu Capital Partners & 2 others	41/100
5th	NUA Surgical 2018, Galway (Ireland), Series A	Developer of specialised surgical retractor to make C-Sections a safer	$6.86M	EQT, TMC Venture Fund & 4 others	41/100
6th	Kove 2019, Zurich (Switzerland), Seed	Provider of surgical device for fetal treatment by fetoscopic interventions	$1.97M	Venturelab, N & V Capital & 2 others	38/100
7th	PeriPear 2024, Oxford (United Kingdom), Unfunded	Developer of a wearable device designed to reduce perineal tearing	-	-	35/100
8th	Reia 2017, New York City (United States), Funding Raised	Developer of non-surgical device for pelvic prolapse	-	MassChallenge, HHS	30/100
9th	Novate Medical 2010, New Orleans (United States), Acquired	Obstetric device to prevent infection	-	Seroba Life Sciences, Omnes Capital & 2 others	30/100
10th	Safe Obstetric Systems 2006, Shenfield (United Kingdom), Acquired	Developer of a device to make the cesarean section safer	-	-	29/100
27th	Advanced Prenatal Therapeutics 2012, Laguna Hills (United States), Funding Raised	Developer of targeted apheresis technology for treating clinical preeclampsia	-	Boma Investments	17/100